Publishing research using ab103477? Please let us know so that we can cite the reference in this datasheet.
ab103477 has been referenced in 1 publication.
Zhao H et al.HDAC2 overexpression is a poor prognostic factor of breast cancer patients with increased multidrug resistance-associated protein expression who received anthracyclines therapy.Jpn J Clin Oncol 46:893-902 (2016).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"